entertainment -WSS

entertainment

author：explore 2025-09-29 16:45:10 - browse：745

The federal government will pay hospitals that treat poor and uninsured patients almost $1 billion less next year. Adobe

The federal government will pay hospitals that treat poor and uninsured patients almost $1 billion less next year, a cut that’s more than eight times larger than the one proposed in April.

The Centers for Medicare and Medicaid Services originally said it would cut payments meant to help safety net hospitals by $115 million in 2024. In the final rule released this week, however, that cut grew to $957 million. The pool of money is known as Medicare’s disproportionate share hospital (DSH) payments and uncompensated care payments.

The agency finalized a bigger cut because it lowered its estimated uninsured rate for next year. CMS explained that even though Medicaid enrollment will shrink as states redetermine members’ eligibility, many of those who didn’t lose Medicaid coverage during the pandemic have since gotten or will get insurance from other sources, like employers — and therefore they will remain insured even when they’re kicked off Medicaid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Ed Silverman on new gene therapies, biosimilars, coffee, and more

explore

focus

WSS

6 phony surgeries that take placebo to the extreme

Trump used to be more articulate. What could explain the change?

Feed a cold, starve a fever? Here’s what science says

Dario to buy mental health app maker Twill in cash and stock deal

Many breast cancer patients receive more radiation than needed

Why palliative psychiatry is worth discussing

focus

entertainment

knowledge

Bright Health sells Medicare Advantage business to Molina

STAT readers on older presidents, polypills, Medicare, and more

In age of alternative facts, a scholarly course on calling out crap

Ed Silverman on new gene therapies, biosimilars, coffee, and more

New air purifier tech could be key to improving indoor air quality

Pennsylvania man bitten on the head by bear during attack in his garage

Guidelines to prevent youth baseball injuries need more muscle

Antivenom research: Lessons from HIV applied in search for universal antidote

Peter Hotez and the public health issue of online harassment

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

leisure time

Alabama IVF ruling threatens families facing fatal genetic disease

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Trump used to be more articulate. What could explain the change?

A new nitrogen execution bill also undermines medical licensing

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Doctors are clamoring for more clarity on Paxlovid prescribing

explore

focus

focus

hotspot